최신 시험


EudraCT Number: 2004-004153-25 Sponsor Protocol Number: JIA6 Start Date: 2004-12-10
Sponsor Name: Royal Hospital For Sick Children, Yorkhill Division
Full Title: Effect of recombinant growth hormone on growth and chondrocyte dynamics in children with juvenile idiopathic arthritis (JIA) and growth failure.
Medical condition: Growth retardation secondary to juvenile idiopathic arthritis
Disease: Version SOC Term Classification Code Term Level
Population Age: Children, Adolescents, Under 18 Gender: Male, Female
Trial protocol: GB (Prematurely Ended)
Trial results: (No results available)

EudraCT Number: 2004-001363-22 Sponsor Protocol Number: TH-CR-302 Start Date: 2004-12-10
Sponsor Name: Threshold Pharmaceuticals
Full Title: A Randomized Phase 3 Study of the Efficacy and Safety of Glufosfamide Compared with Best Supportive Care in Metastatic Pancreatic Adenocarcinoma Previously Treated with Gemcitabine
Medical condition: Previously treated metastatic pancreatic adenocarcinoma
Disease: Version SOC Term Classification Code Term Level
7.0 10033599 LLT
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: CZ (Completed)
Trial results: (No results available)
EudraCT Number: 2004-002821-30 Sponsor Protocol Number: 12 Start Date: 2004-12-09
Sponsor Name: Institute of Oncology, Vilnius University
Full Title: Study of the efficacy of intravesical instillations of interleukin-2 in treatment of superficial bladder cancer
Medical condition: Ta,T1 /G1,G2,G3 superficial bladder cancer
Disease: Version SOC Term Classification Code Term Level
9.1 10005003 Bladder cancer LLT
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: LT (Prematurely Ended)
Trial results: (No results available)

EudraCT Number: 2004-004010-17 Sponsor Protocol Number: ANG206 Start Date: 2004-12-09
Sponsor Name: Amersham plc and its Amersham Health affiliates, trading as GE Healthcare
Full Title: An open-label, multi-centre, phase 2a study to assess the feasibility and safety of intravenous bolus administration of 99mTc-NC100692 Injection in imaging metastases in late stage cancer patients.
Medical condition: The subjects to be included in this study have been diagnosed with primary breast, lung (non-small cell), ovarian or prostate cancer or malignant melanoma and have metastatic spread of the cancer t...
Disease: Version SOC Term Classification Code Term Level
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: SE (Prematurely Ended) GB (Completed) DE (Completed) ES (Completed)
Trial results: View results
EudraCT Number: 2004-003887-31 Sponsor Protocol Number: 2004/116 Start Date: 2004-12-09
Sponsor Name: Klinisk Farmakologisk Center og Med. Afd. M, Århus Sygehus, NBG
Full Title: "Farmakodynamiske egenskaber af to langtidsvirkende insulinanaloger i sammenligning med NPH insulin"
Medical condition: Healthy subjects.
Disease: Version SOC Term Classification Code Term Level
Population Age: Adults Gender: Male
Trial protocol: DK (Ongoing)
Trial results: (No results available)

EudraCT Number: 2004-000654-23 Sponsor Protocol Number: EORTC 18032 Start Date: 2004-12-09
Sponsor Name: EORTC
Full Title: Extended schedule, escalated dose Temozolomide versus Dacarbazine in Stage IV Metastatic Melanoma: A Randomized Phase III Study of the EORTC Melanoma Group
Medical condition: Stage IV Metastatic Melanoma:
Disease: Version SOC Term Classification Code Term Level
7.0 10027480 PT
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: ES (Ongoing) GB (Prematurely Ended) BE (Completed)
Trial results: View results
EudraCT Number: 2004-001243-30 Sponsor Protocol Number: 840 30 40 Start Date: 2004-12-09
Sponsor Name: Apogepha Arzneimittel GmbH
Full Title: Propiverine hydrochloride in children suffering from overactive bladder and urinary incontinence. A randomised, double-blind, placebo-controlled, parallel grouped multicentre clinical trial.
Medical condition: children suffering from overactive bladder and urinary incontinence
Disease: Version SOC Term Classification Code Term Level
Population Age: Children, Under 18 Gender: Male, Female
Trial protocol: CZ (Completed) SK (Completed) AT (Completed) SE (Completed) NL (Completed)
Trial results: (No results available)

EudraCT Number: 2004-003341-40 Sponsor Protocol Number: PREEMPT 2005 Start Date: 2004-12-08
Sponsor Name: University of Oxford
Full Title: PRE-EMPT: Prevention of Mood Disorders by Folic Acid Supplement.
Medical condition: Mood disorder
Disease: Version SOC Term Classification Code Term Level
Population Age: Adolescents, Under 18, Adults Gender: Male, Female
Trial protocol: GB (Completed)
Trial results: View results
EudraCT Number: 2004-001511-54 Sponsor Protocol Number: A5951060 Start Date: 2004-12-08
Sponsor Name: Pfizer Global Research and Development
Full Title: Linezolid vs. Vancomycin/Oxacillin/Dicloxacillin in the Treatment of Catheter-Related Gram Positive Bloodstream Infections.
Medical condition: Catheter related gram positive bloodstream infection
Disease: Version SOC Term Classification Code Term Level
10007810 LLT
Population Age: Adolescents, Under 18, Adults Gender: Male, Female
Trial protocol: IE (Completed)
Trial results: View results

EudraCT Number: 2004-000763-98 Sponsor Protocol Number: HP184B/2002 Start Date: 2004-12-08
Sponsor Name: Aventis Pharmaceuticals Inc.
Full Title: A phase II, double-blind, placebo-controlled, multicenter study to assess the efficacy and safety of HP184 at 100, 200 and 400 mg doses administered orally once daily for twenty-four weeks in adult...
Medical condition: Chronic spinal cord injury
Disease: Version SOC Term Classification Code Term Level
Population Age: Adults Gender: Male, Female
Trial protocol: GB (Completed) DE (Completed)
Trial results: View results
3